Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Effective drug delivery systems are essential in maximizing the therapeutic effects of the drugs in question. This book thoroughly analyses recent technological advances in new, nanomaterial-based drug delivery systems for the diagnosis and treatment of various diseases. These systems also have diverse applications in pharmaceutical, biomedical, biomaterial, and biotechnological fields. This book explains the different types of nanocarriers currently in development and covers both therapeutic and theranostic applications of drug-loaded nanocarriers and nanomedicine. Clinical research…mehr
Effective drug delivery systems are essential in maximizing the therapeutic effects of the drugs in question. This book thoroughly analyses recent technological advances in new, nanomaterial-based drug delivery systems for the diagnosis and treatment of various diseases. These systems also have diverse applications in pharmaceutical, biomedical, biomaterial, and biotechnological fields. This book explains the different types of nanocarriers currently in development and covers both therapeutic and theranostic applications of drug-loaded nanocarriers and nanomedicine.
Clinical research professionals, industrial pharmaceutical scientists, and veteran drug delivery developers benefit from the unique structure of this book, making it essential for the drug delivery researcher. Students, research scholars, and industrial professionals alike benefit from the current technological advancements, regulatory aspects, and the history of discovery and development in the field of nanomedicine presented in this book.
Dr. Chandrakantsing Pardeshi holds Ph.D. degree in Pharmaceutical Sciences from Kavayitri Bahinabai Chaudhari North Maharashtra University (KBC NMU, Jalgaon, India). He has been involved in the development of various nanocarrier formulations for direct nose to brain drug delivery since last decade. His active areas of research includes nasal drug delivery, development of nanoparticulate formulations for pharmaceutical and biomedical applications, and polymer modifications for utilization in drug delivery. Currently, he is inventing new drug administration devices for nasal and pulmonary applications in his laboratory. He has authored more than 52 peer-reviewed international research and review articles, 1 edited book, 21 book chapters, 19 conference presentations, 1 funded research project from UGC, Government of India. He has filed 2 Indian patent applications on novel neuronanoemulsion formulations for direct nose to brain drug delivery. He is an active referee for several reputedrefereed journals. He is a recipient of the Gold Medal from KBC NMU (Jalgaon, India), Excellence Award from Indian Drug Manufacturer’s Association (Mumbai, India), Young Faculty Award (Kolkata, India). He has been enlisted in the Top 2% Scientists in the World Ranking released by Stanford University (USA) for two consecutive years (2021 & 2022).
Inhaltsangabe
Section-I: Introduction to nanomaterials for drug delivery.- Introduction to Nanomaterials for drug delivery.- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications.- Polymer-based nanomaterials.- Lipid-based nanomaterials.- Vesicular nanomaterials.- Hybrid nanomaterials.- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications.- Magnetic nanoparticles.- Quantum dots.- Upconversion nanoparticles.- Gold nanoparticles.- Carbon-based nanoparticles.- Graphene-based nanoparticles.- Section-IV: Nanomaterials toxicity & clinical translation.- Nanotoxicology: an overview.- Patenting nanomaterials: Regulatory aspects.- Clinical perspectives: Translating nanomaterials from laboratory to clinic.
Section-I: Introduction to nanomaterials for drug delivery.- Introduction to Nanomaterials for drug delivery.- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications.- Polymer-based nanomaterials.- Lipid-based nanomaterials.- Vesicular nanomaterials.- Hybrid nanomaterials.- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications.- Magnetic nanoparticles.- Quantum dots.- Upconversion nanoparticles.- Gold nanoparticles.- Carbon-based nanoparticles.- Graphene-based nanoparticles.- Section-IV: Nanomaterials toxicity & clinical translation.- Nanotoxicology: an overview.- Patenting nanomaterials: Regulatory aspects.- Clinical perspectives: Translating nanomaterials from laboratory to clinic.
Section-I: Introduction to nanomaterials for drug delivery.- Introduction to Nanomaterials for drug delivery.- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications.- Polymer-based nanomaterials.- Lipid-based nanomaterials.- Vesicular nanomaterials.- Hybrid nanomaterials.- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications.- Magnetic nanoparticles.- Quantum dots.- Upconversion nanoparticles.- Gold nanoparticles.- Carbon-based nanoparticles.- Graphene-based nanoparticles.- Section-IV: Nanomaterials toxicity & clinical translation.- Nanotoxicology: an overview.- Patenting nanomaterials: Regulatory aspects.- Clinical perspectives: Translating nanomaterials from laboratory to clinic.
Section-I: Introduction to nanomaterials for drug delivery.- Introduction to Nanomaterials for drug delivery.- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications.- Polymer-based nanomaterials.- Lipid-based nanomaterials.- Vesicular nanomaterials.- Hybrid nanomaterials.- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications.- Magnetic nanoparticles.- Quantum dots.- Upconversion nanoparticles.- Gold nanoparticles.- Carbon-based nanoparticles.- Graphene-based nanoparticles.- Section-IV: Nanomaterials toxicity & clinical translation.- Nanotoxicology: an overview.- Patenting nanomaterials: Regulatory aspects.- Clinical perspectives: Translating nanomaterials from laboratory to clinic.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497